Evogene Ltd

Last updated September 27, 2026

Organization details

Legal name
Evogene Ltd
Ownership
Public
Status
Active
Sector (GICS)
Materials
SIC code
2870 — Agricultural Chemicals
Jurisdiction of incorporation
Israel
Headquarters city
Rehovot
Headquarters country
Israel
Fiscal year end
December
Ticker symbol
EVGN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001574565

Board of directors

Chief executives

Ofer Haviv · President and CEO
Since March 2026

Board connections

4 of this board's directors also sit on 8 other boards.

Network of Evogene Ltd's board connections Innoviz Technologies Ltd. Innoviz Technologies L... Kamada Ltd. Kamada Ltd. NICE Ltd NICE Ltd Nexera Technologies Ltd Nexera Technologies Lt... Odysight.ai Inc. Odysight.ai Inc. Polyrizon Ltd. Polyrizon Ltd. Rail Vision Ltd. Rail Vision Ltd. Wearable Devices Ltd. Wearable Devices Ltd. Dan Michael Falk Dan Michael Falk Leon Recanati Leon Recanati Nir Nimrodi Nir Nimrodi Oz Adler Oz Adler Evogene Ltd
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$695,077
3 purchases by 2 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 11, 2026 Leon Recanati Director Open-market purchase +460,000 $0.64 $294,400
Aug 4, 2026 Leon Recanati Director Open-market purchase +800,000 $0.50 $400,000
Jun 4, 2026 Tarcic Gabi Officer (Chief Development Officer) Open-market purchase +1,129 $0.60 $677

Organizations in the same sector, closest in location and size first.

Questions about Evogene Ltd

Who is the CEO of Evogene Ltd?

Ofer Haviv has been Evogene Ltd's President and CEO since March 2026.

How many directors are on Evogene Ltd's board?

Evogene Ltd's board has 8 directors: Adi Zuloff-Shani, Adrian John Percy, Dan Michael Falk, Leon Recanati, Nir Nimrodi, Ofer Haviv, Oz Adler and Sarit Firon.

Are Evogene Ltd insiders buying or selling shares?

Over the last 12 months, Evogene Ltd insiders bought $695,077 of shares in 3 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="evogene-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.